Institutional Ownership Changes (13F Filings) for Novus Therapeutics (NASDAQ:NVUS)
Institutional Ownership Percentage: 45.29%
Novus Therapeutics (NASDAQ NVUS) Institutional Buying and Selling
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | |
|---|
| 8/17/2019 | Orbimed Advisors LLC | 3,183,314 | $3.22M | 0.0% | +25.5% | 24.525% | |
| 8/14/2019 | Citadel Advisors LLC | 39,647 | $40K | 0.0% | N/A | 0.306% | |
| 8/14/2019 | Vanguard Group Inc. | 270,160 | $0.27M | 0.0% | +528.2% | 2.082% | |
| 8/13/2019 | BlackRock Inc. | 33,544 | $34K | 0.0% | +69.2% | 0.259% | |
| 8/5/2019 | National Asset Management Inc. | 270,000 | $0.27M | 0.0% | +69.1% | 2.081% | |
| 5/8/2019 | National Asset Management Inc. | 159,705 | $0.64M | 0.1% | +32.8% | 1.693% | |
| 5/6/2019 | Seelaus Asset Management LLC | 10,000 | $40K | 0.0% | N/A | 0.106% | |
| 4/1/2019 | Deutsche Bank AG | 50,846 | $81K | 0.0% | -30.3% | 0.539% | |
| 2/8/2019 | National Asset Management Inc. | 120,219 | $0.19M | 0.0% | +167.2% | 1.276% | |
| 12/13/2018 | Vanguard Group Inc | 135,599 | $0.63M | 0.0% | +73.5% | 1.439% | |
| 11/23/2018 | Vanguard Group Inc. | 135,599 | $0.63M | 0.0% | +73.5% | 1.439% | |
| 11/13/2018 | Renaissance Technologies LLC | 251,556 | $1.18M | 0.0% | +28.6% | 2.670% | |
| 11/8/2018 | National Asset Management Inc. | 45,000 | $0.21M | 0.0% | +345.9% | 0.478% | |
| 8/13/2018 | Renaissance Technologies LLC | 195,588 | $1.37M | 0.0% | +78.0% | 2.076% | |
| 5/21/2018 | Derby & Company Inc. | 29,545 | $0.15M | 0.1% | +60.3% | 0.314% | |
| 2/15/2018 | Lyon Street Capital LLC | 338,929 | $1.38M | 0.5% | +102.3% | 4.780% | |
| 11/14/2017 | Lyon Street Capital LLC | 167,577 | $0.87M | 0.3% | +311.1% | 2.364% | |
| 8/14/2017 | Lyon Street Capital LLC | 40,766 | $0.24M | 0.1% | N/A | 5.509% | |
(Data available from 1/1/2016 forward)
